Annotation Detail

Information
Associated Genes
TP53
Associated Variants
TP53 DELETERIOUS MUTATION
TP53 DELETERIOUS MUTATION
Associated Disease
adrenocortical carcinoma
Source Database
CIViC Evidence
Description
TP53 mutation was shown to be associated with shorter overall survival in patients with adrenocortical tumors (log-rank test; P=0.098). Of 20 patients studied, 5 had coding mutation in TP53. Four of the 5 patients with a TP53 mutation had metastases at diagnosis or detected soon thereafter, and 3 of 4 died of disease within 12 months of surgical resection.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1028
Gene URL
https://civic.genome.wustl.edu/links/genes/45
Variant URL
https://civic.genome.wustl.edu/links/variants/222
Rating
2
Evidence Type
Prognostic
Disease
Adrenocortical Carcinoma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
15922892
Drugs